0001209191-23-048905.txt : 20230911
0001209191-23-048905.hdr.sgml : 20230911
20230911135212
ACCESSION NUMBER: 0001209191-23-048905
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230907
FILED AS OF DATE: 20230911
DATE AS OF CHANGE: 20230911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Huizenga Theodore Alan
CENTRAL INDEX KEY: 0001603347
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36276
FILM NUMBER: 231247446
MAIL ADDRESS:
STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC.
STREET 2: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc.
CENTRAL INDEX KEY: 0001515673
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272546083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 415-483-8800
MAIL ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-07
0
0001515673
Ultragenyx Pharmaceutical Inc.
RARE
0001603347
Huizenga Theodore Alan
C/O ULTRAGENYX PHARMACEUTICAL INC.
60 LEVERONI COURT
NOVATO
CA
94949
0
1
0
0
SVP, Chief Accounting Officer
0
Common Stock
2023-09-07
4
M
0
2000
21.00
A
25777
D
Common Stock
2023-09-07
4
S
0
2000
41.00
D
23777
D
Common Stock
2023-09-07
4
S
0
163
38.34
D
23614
D
Stock Option (Right to Buy)
21.00
2023-09-07
4
M
0
2000
0.00
D
2024-01-29
Common Stock
2000
3000
D
The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023.
Includes previously reported shares of common stock underlying restricted stock units granted to the Reporting Person, which are subject to certain vesting conditions.
1/4th of the option vested one year from January 29, 2014 and then 1/48th of the option vested monthly thereafter.
/s/ Karah Parschauer, attorney-in-fact
2023-09-11